An18-vear-old man presentstothehaematooqvclinicforreview.Hehassufferedasecond sianificant
episodeofhaemotysisinthepastyear andisunabetocompletehisA-levelsduetochroniciuess.Youplan
tocommencehimon eculizumabtherapy
WhichofthefoLLowinarepresentsthemodeof action ofeculizumab?
Anti-CD20
Anti-TNF
C5inhibitor
CTLA4lg
PD-1inhibitor
@1MINNDOCRINE
